Article
Methotrexate-related response on human peripheral blood mononuclear cells may be modulated by the Ala16Val-SOD2 gene polymorphism.
PloS one - 1 Jan 2014
Barbisan Fernanda, Motta Jéssica de Rosso, Trott Alexis, Azzolin Verônica, Dornelles Eduardo Bortoluzzi, Marcon Matheus, Algarve Thaís Doeler, Duarte Marta Maria Medeiros Frescura, Mostardeiro Clarice Pinheiro, Unfer Taís Cristina, Schott Karen Lilian, da Cruz Ivana Beatrice Mânica
Abstract excerpt
Methotrexate (MTX) is a folic acid antagonist used in high doses as an anti-cancer treatment and in low doses for the treatment of some autoimmune diseases. MTX use has been linked to oxidative imbalance, which may cause multi-organ toxicities that can be attenuated by antioxidant supplementation. Despite the oxidative effect of MTX, the influence of antioxidant gene polymorphisms on MTX toxicity is not well...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
